Discovery of phage CSF, a novel generalist bacteriophage targeting multidrug-resistant and potentially pathogenic Staphylococcus spp. and Mammaliicoccus spp.
Authors:
- 29 July 2025
- journal article
- research article
- Published by Springer Nature in Archives of Virology
- Vol. 170 (8) , 1-13
Abstract
Antimicrobial resistance is escalating among Staphylococcus species, which are major pathogens affecting both humans and animals. As therapeutic options continue to narrow, phage therapy is re-emerging as a promising strategy to combat resistant strains. In this study, we isolated from pig farm effluents a bacteriophage named CSF, infecting a Staphylococcus xylosus strain. The CSF phage demonstrated a broad host range, lysing mecA-positive, multidrug-resistant strains across nine species of the genera Staphylococcus and Mammaliicoccus. Notably, it also inhibited biofilm formation in strains that it could not infect directly, and this activity persisted at low virus concentrations and in combination with antibiotics. The phage maintained its lytic activity under extreme conditions of temperature, pH, and UV exposure, underscoring its resilience for practical use. Sequencing of the viral genome revealed that it is 140 kb in length and has a genetic composition consistent with a lytic lifestyle. Phylogenetic analysis showed that phage CSF is related to members of the family Herelleviridae that are found globally, suggesting a widespread distribution of related viral lineages. Importantly, the phage genome was found to lack bacterial virulence or antimicrobial resistance genes, suggesting its safety for biotechnological applications. Intergenomic comparisons indicated that CSF should be classified as a member of a new genus, expanding the known diversity of bacteriophages. These findings demonstrate potential of CSF for phage therapy and other biotechnological applications.Keywords
Funding Information
- Conselho Nacional das Fundações Estaduais de Amparo à Pesquisa (313528/2021-7, 304839/2022-1; 408564/2023-7; 309158/2023-0)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (23038.002486/2018-26)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E-26/010.000172/2016; 010.00128/2016; E-26.210.875/2016, 101056/2018; 001463/2019; 211.554/2019; 201.071/2020,200.895/2021; E-26/204.925/2022; E-26/211.284/2021 and E-26/204.045/2024)
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (APQ-03498-22; APQ-01339-25)
This publication has 44 references indexed in Scilit:
- From Farm to Community: Dispersal of Potentially Pathogenic Staphylococcus and Mammaliicoccus Species and Antimicrobial Resistance Across Shared EnvironmentsCurrent Microbiology, 2025
- Mammaliicoccus sciuri’s Pan-Immune System and the Dynamics of Horizontal Gene Transfer Among Staphylococcaceae: a One-Health CRISPR TaleJournal of Microbiology, 2024
- Antimicrobial resistance: Impacts, challenges, and future prospectsJournal of Medicine, Surgery, and Public Health, 2024
- Staphylococcus haemolyticus: An updated review on nosocomial infections, antimicrobial resistance, virulence, genetic traits, and strategies for combating this emerging opportunistic pathogenMicrobiological Research, 2024
- Tenebrio molitor as a model system to study Staphylococcus spp virulence and horizontal gene transferMicrobial Pathogenesis, 2023
- Interspecies transfer of plasmid-borne gentamicin resistance between Staphylococcus isolated from domestic dogs to Staphylococcus aureusInfection, Genetics and Evolution, 2022
- Targeting biofilms using phages and their enzymesCurrent Opinion in Biotechnology, 2021
- Phenotypic and Genotypic Characterization of Biofilm Formation in Staphylococcus haemolyticusCurrent Microbiology, 2015
- Phages of Staphylococcus aureus and their impact on host evolutionInfection, Genetics and Evolution, 2014
- Methicillin-resistant Staphylococcus aureus in Rio de Janeiro hospitals: Dissemination of the USA400/ST1 and USA800/ST5 SCCmec type IV and USA100/ST5 SCCmec type II lineages in a public institution and polyclonal presence in a private oneAmerican Journal of Infection Control, 2013